Fosun Pharma, with its pharmaceutical business as the core, insists on innovative research and development, and through independent research and development, cooperative development, licensing and in-depth incubation, it has built and formed a platform for small molecule innovative medicines, antibody medicines, and cellular therapies in the key disease areas of oncology and immunomodulation, the four highs (hypertension, hyperlipidemia, hyperglycemia, and hyperuria) and their complications, and the central nervous system, and has actively explored targeted protein degradation and cellular therapy. Actively explore targeted protein degradation, RNA, lysogenic viruses, gene therapy and other cutting-edge technology areas to enhance innovation capabilities.